Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neural mechanisms in asthma.

P J Barnes1

  • 1Department of Thoracic Medicine, National Heart & Lung Institute, London, UK.

British Medical Bulletin
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Neural control abnormalities in asthma may involve increased cholinergic activity and potential dysfunction of inhibitory non-adrenergic, non-cholinergic (i-NANC) nerves, impacting airway tone and inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid resistance in asthma.

American journal of respiratory and critical care medicine·1995
Same author

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.

The Journal of experimental medicine·1995
Same author

Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

Molecular pharmacology·1995
Same author

Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages.

The American journal of physiology·1995
Same author

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction.

Thorax·1995
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Area of Science:

  • Respiratory physiology
  • Neuroimmunology
  • Pharmacology

Background:

  • Asthma pathophysiology involves neurogenic mechanisms.
  • Cholinergic nerves are the primary bronchoconstrictor pathway.
  • Inflammatory mediators may enhance cholinergic neurotransmission in asthma.

Purpose of the Study:

  • To investigate neural control abnormalities in asthma.
  • To explore the role of cholinergic and non-adrenergic, non-cholinergic (NANC) nerves in asthma.
  • To examine potential defects in prejunctional receptors and neuropeptide release.

Main Methods:

  • Review of existing literature on neural control in asthma.
  • Analysis of cholinergic and adrenergic receptor function.
  • Investigation of inhibitory NANC nerve pathways and neuropeptide involvement.

Related Experiment Videos

Main Results:

  • Cholinergic neurotransmission may be increased in asthma.
  • Defects in prejunctional M2-receptors might enhance cholinergic effects.
  • Inhibitory NANC nerve function may be impaired in asthma.
  • Sensory nerves may release inflammatory peptides like substance P and neurokinin A.

Conclusions:

  • Neurogenic mechanisms significantly contribute to asthma pathophysiology.
  • Dysregulation of cholinergic and i-NANC pathways are implicated in asthma.
  • Inflammatory peptides released from sensory nerves may play a role in chronic asthma inflammation.